Molecularly Redefining Small Bowel Adenocarcinoma to Accelerate Precision Patient Care
Recruiting
Observational Study
Small Bowel Adenocarcinoma
No Study Drug
Researchers observe your health over time — no experimental treatment is given.
At a Glance
- Age
- 18 and older
- Sex
- Any
- Study type
- Observational
- Participants needed
- 500 (estimated)
- Sponsor
- Copenhagen University Hospital at Herlev · Other
Think this trial could be right for you?
Answer a few quick questions to see if you may meet the eligibility requirements.
Check Your Eligibility
About This Trial
Small bowel adenocarcinoma is a rare malignancy, and there is limited knowledge about its optimal clinical management and molecular background. The SBAMOL study is an observational biomarker study that aims to identify prognostic and predictive biomarkers. This effort is intended to lay the groundwork for personalized medicine tailored to this specific patient group.
Trial Locations
Loading…
Loading trial locations…
Eligibility Criteria
Inclusion criteria:
Patients with histologically verified small bowel adenocarcinoma Patients older than 18 years
Exclusion criteria:
Insufficient material for molecular testing Patients registered in Vævsanvendelsesregistret\&
Vævsanvendelsesregistret; refers to a central Danish registry where …
Contacts